- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
IKEA UK customers will be offered home insurance at the point of sale (POS) when purchasing the retailer’s products through its partnership with Urban Jungle. The shift toward embedding insurance products alongside other products poses an immediate threat to incumbent insurers stuck using legacy channels, says GlobalData, a leading intelligence and productivity platform. According to […]
Harvey Nichols can bounce back under Frasers Group, says GlobalData
The contrasting fortunes of Harrods, Harvey Nichols, Fenwick and John Lewis & Partners highlights how sharply the UK department store channel is diverging. While Harrods has returned to profit, Fenwick is showing early signs of a turnaround and John Lewis & Partners is undergoing a strategic reset under new leadership. Harvey Nichols, by contrast, is […]
India VC deals down, funding value edges up in January–July 2026, reveals GlobalData
India’s venture capital (VC) funding landscape experienced mixed market dynamics during the first seven months (January-July) of 2026. The total number of VC deals announced declined by 13% and total funding recorded a modest year-on-year (YoY) growth of 5%, reveals GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “This […]
UK VC funding value soars 113% YoY despite flat deal activity during January–July 2026, finds GlobalData
The UK’s venture capital (VC) ecosystem demonstrated remarkable resilience during the first seven months (January–July) of 2026, recording a more than two-fold (113%) expansion year-on-year (YoY) in total capital deployed despite stagnant deal volume, reveals GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The trend suggests a pronounced shift […]
China VC funding value sees over three-fold surge in January–July 2026, reveals GlobalData
China’s venture capital (VC) activity registered substantial growth during the first seven months of 2026, characterized by robust double-digit expansion in transaction count and a more than three-fold leap in capital deployment. The total number of VC deals announced in China increased by 34% during January–July 2026 compared to the same period in 2025, whereas […]
US VC funding value nearly triples in January-July 2026, reveals GlobalData
The US venture capital (VC) activity recorded a sharp acceleration in funding value during the first seven months of 2026, reinforcing the country’s position as the hotbed for global VC investment. Total VC funding value in the US surged by 199% during January-July 2026 compared to the same period in the previous year even as […]
Daraxonrasib approval changes standard of care in second-line pancreatic cancer, says GlobalData
The US FDA approval of Revolution Medicine’s Rasonque (daraxonrasib) changes the standard of care in second-line pancreatic cancer, as the oral therapy will displace the intensive and complicated-to-administer chemotherapy regimens currently used in practice, revealsGlobalData, a leading intelligence and productivity platform. Israel Stern, Healthcare Senior Analyst at GlobalData, comments. “Unlike first-generation RAS inhibitors, that only bind […]
Biogen’s felzartamab approval to intensify competition in crowded multiple myeloma market in China, says GlobalData
China has recently approved TJ Biopharma’s felzartamab (Jingfei) as the third CD38 inhibitor for multiple myeloma, marking the first approved indication for the drug. This approval marks entry of Biogen into the oncology commercial space in China and intensifies competition in an already crowded multiple myeloma market, according to GlobalData, a leading intelligence and productivity […]
Europe’s policies to shape offshore wind as next frontier in renewable power, says GlobalData
Europe is moving into an offshore wind “supremacy phase” as governments shift from ambition to execution, locking in multi‑gigawatt pipelines with redesigned auctions, clearer revenue stabilization tools, and faster permitting rules, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Europe Renewable Energy Policy Handbook 2026,” reveals that offshore wind is increasingly […]
Oil and gas companies remain key adopters of CCUS despite project delivery challenges, says GlobalData
Carbon capture, utilization, and storage (CCUS) has become an important decarbonization pathway for oil and gas, power, cement, steel and other hard-to-abate industries. As of June 2026, more than 70% of operational and upcoming carbon capture facilities, by facility count, were associated with energy assets, with oil and gas companies remaining key participants, even though […]
KDDI’s shift to vetted ‘walled garden’ content model highlights importance of reliability-based differentiation in consumer AI, says GlobalData
KDDI in Japan is sharpening telco-enabled differentiation in consumer AI with Buffmee, a conversational search and study assistant designed around accuracy, reliability, and trustworthiness rather than broad, uncurated internet retrieval. Buffmee shows how a telco can make consumer GenAI feel more accountable by narrowing the reference set to a vetted publisher ecosystem, according to GlobalData, […]
English Premier League Front of Shirt sponsorship resilient despite ban of gambling brands, reveals GlobalData
With the ban of gambling brands featuring on the front of shirt deals in the English Premier League coming into effect; Conrad Wiacek, Head of Sport Analysis at GlobalData, a leading intelligence and productivity platform, offers his view: “Front of Shirt (FOS) sponsorship in the English Premier League is projected to come in at around […]
China to dominate global butadiene capacity additions through 2030, says GlobalData
China is poised to significantly expand butadiene production capacity to meet strong domestic demand from the automotive and tire sectors while reducing its reliance on foreign imports. The country is set to retain its position as the world’s largest contributor to butadiene capacity additions through 2030, according to GlobalData, a leading intelligence and productivity platform. […]
India nephrology and urology devices market to grow at 7% CAGR through 2035, forecasts GlobalData
Demand for nephrology and urology devices is rising across India, driven by the growing need for kidney disease diagnosis, monitoring, and accessible healthcare technologies. Against this backdrop, India’s nephrology and urology devices market is projected to grow at a compound annual growth rate (CAGR) of 7% between 2025 and 2035, according to GlobalData, a leading […]
Google’s Pixel production shift from China ignites influencer debate on gains for India and Vietnam, reveals GlobalData
Google’s reported plan to shift all Pixel device manufacturing out of China by 2027 has sparked significant discussion among influencers on X, following a Nikkei Asia report stating that the company has told suppliers it will relocate production of Pixel smartphones, smartwatches, and wireless earbuds primarily to India and Vietnam. The surge in discussion was […]
APAC deal activity down 11% YoY in first seven months of 2026, reveals GlobalData
The total number of deals (mergers & acquisitions (M&A), private equity and venture capital (VC)) announced across the Asia-Pacific (APAC) region year-on-year (YoY) decreased by around 11% during January–July 2026, reflecting a broad-based cooling in deal-making appetite, reveals GlobalData, a leading intelligence and productivity platform. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The overall contraction […]
Moderna’s melanoma vaccine sales forecast to surpass $1 billion by 2031 following landmark Phase III win, forecasts GlobalData
Sales of Moderna and Merck’s personalized cancer vaccine intismeran autogene are projected to surpass $1 billion by 2031, following positive Phase III INTerpath-001 results in high-risk resected melanoma, reveals GlobalData, a leading intelligence and productivity platform . Intismeran autogene, given alongside Merck’s Keytruda (pembrolizumab), met its primary endpoint of statistically significant recurrence-free survival and its […]
Global deal activity falls 6% YoY in first seven months of 2026, reveals GlobalData
Global deal activity has been on a downward trajectory in 2026, reflecting a more cautious approach among dealmakers, as macro uncertainty and extended decision cycles continued to influence transaction execution. The total number of deals (comprising mergers & acquisitions (M&A), private equity and venture capital (VC)) announced globally decreased by around 6% during January–July 2026 […]
Chronic kidney disease market to reach $10.9 billion across 7MM by 2035, forecasts GlobalData
The chronic kidney disease (CKD) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 9.8% from $4.3 billion in 2025 to $10.9 billion in 2035, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report “Chronic Kidney Disease: Disease Analysis and Forecast” reveals […]
APAC gastroscopes market to grow at 11% CAGR through 2035, forecasts GlobalData
Asia-Pacific (APAC) is witnessing a rising disease burden of stomach cancer and gastroesophageal reflux disease, driven by changing lifestyles, dietary patterns, and increasing obesity rates. Against this backdrop, the APAC gastroscopes market is projected to grow at a compound annual growth rate (CAGR) of 11% through 2035, forecasts GlobalData, a leading intelligence and productivity platform. […]